Ungell ADME Consulting AB

is a company in the area of ADME and DMPK related research. The Company was formed in April 2020 and offers consulting services for example, but not exclusively:

Outlining experimental strategies of necessary knowledge and risk of ADME related properties
   of molecules in Early discovery and during the pre-clinical stage

In depth understanding of ADME tools and interpretation of data

Understanding and risk-assessment of involvement of transporters and enzymes for clinical
   development as well as advice for both in vitro and in vivo studies to minimize the risk

Understanding of absorption routes and level and in relation to formulation activities

Coaching for collaboration between departments and research areas
   to optimize delivery for Clinical candidates